Targeting Glucagon-Like Peptide 1 Signaling: A Potential Disease Modifying Therapy for Parkinson's Disease

被引：1
|
作者：
Kimura, Yasuyoshi [1 ]
Mochizuki, Hideki [1 ]
机构：
[1] Osaka Univ, Grad Sch Med, Dept Neurol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan
来源：
MOVEMENT DISORDERS | 2024年 / 39卷 / 07期
基金：
日本科学技术振兴机构; 日本学术振兴会;
关键词：
D O I：
10.1002/mds.29884
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1087 / 1087
页数：1
相关论文
共 50 条
  • [1] Role of glucagon-like peptide-1 receptor agonists in Alzheimer's disease and Parkinson's disease
    Hong, Chien-Tai
    Chen, Jia-Hung
    Hu, Chaur-Jong
    JOURNAL OF BIOMEDICAL SCIENCE, 2024, 31 (01)
  • [2] Glucagon-like peptide 1 in health and disease
    Andersen, Andreas
    Lund, Asger
    Knop, Filip K.
    Vilsboll, Tina
    NATURE REVIEWS ENDOCRINOLOGY, 2018, 14 (07) : 390 - 403
  • [3] Glucagon-like peptide 1 in health and disease
    Andreas Andersen
    Asger Lund
    Filip K. Knop
    Tina Vilsbøll
    Nature Reviews Endocrinology, 2018, 14 : 390 - 403
  • [4] The therapeutic potential of targeting the glucagon-like peptide-2 receptor in gastrointestinal disease
    Hornby, Pamela J.
    Moore, Beverley A.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (05) : 637 - 646
  • [5] Glucagon-Like Peptide 1 Receptor Agonists in Alzheimer’s Disease
    Xue Qiao-Qiao Wang
    Tian-Tian Yan
    Ling-Hui Wang
    Neurochemical Journal, 2023, 17 : 243 - 246
  • [6] Glucagon-Like Peptide 1 Receptor Agonists in Alzheimer's Disease
    Wang, Qiao-Qiao
    Yan, Xue
    Wang, Tian-Tian
    Zeng, Ling-Hui
    NEUROCHEMICAL JOURNAL, 2023, 17 (02) : 243 - 246
  • [7] Therapeutic Potential of Glucagon-Like Peptide-1 Cleavage Product for Alzheimer’s Disease
    Stephen M. Day
    Tao Ma
    Neuroscience Bulletin, 2019, 35 : 934 - 936
  • [8] Potential new therapeutic target for Alzheimer's disease: Glucagon-like peptide-1
    Liu, Xiao-Yu
    Zhang, Ni
    Zhang, Sheng-Xiao
    Xu, Ping
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2021, 54 (10) : 7749 - 7769
  • [9] Therapeutic Potential of Glucagon-Like Peptide-1 Cleavage Product for Alzheimer's Disease
    Day, Stephen M.
    Ma, Tao
    NEUROSCIENCE BULLETIN, 2019, 35 (05) : 934 - 936
  • [10] The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action
    Athauda, Dilan
    Foltynie, Thomas
    DRUG DISCOVERY TODAY, 2016, 21 (05) : 802 - 818
12345